Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
If you are still deciding whether care is right for you, check your eligibility before you make any changes
Eli Lilly's December 2025 TRIUMPH-4 topline release reported approximately 28.7% mean body-weight loss over 68 weeks at 12 mg among the largest averages reported in any Phase 3 obesity trial though that readout was in a knee-osteoarthritis population, so the broader TRIUMPH-1 result is still pending
Individual experiences vary, and certain clinical circumstances may predispose patients to feeling dizzy or light-headed whilst on this medication
The research question dictates the product
It does not replace training
US$ 29.56
US$ 20.60
US$ 27.72
US$ 29.83
